Eli Lilly and Revenue 2024

The Eli Lilly and Revenue history

YEAR	REVENUE (undefined USD)	GROSS MARGIN (%)
2029e	75.18	35,97
2028e	69.13	39,12
2027e	63.98	42,27
2026e	61.79	43,77
2025e	52.23	51,78
2024e	41.8	64,70
2023	34.12	79,25
2022	28.54	76,77
2021	28.32	74,18
2020	24.54	77,66
2019	22.32	78,84
2018	21.49	78,22
2017	19.97	77,73
2016	21.22	73,35
2015	19.96	74,76
2014	19.62	74,85
2013	23.11	78,77
2012	22.6	78,78
2011	24.29	79,13
2010	23.08	81,08
2009	21.84	80,55
2008	20.37	78,51
2007	18.63	77,20
2006	15.69	77,40
2005	14.65	76,28
2004	13.86	76,74

Eli Lilly and Aktienanalyse

What does Eli Lilly and do?

Eli Lilly and Co. is a global biopharmaceutical company headquartered in Indianapolis, Indiana, USA. The company was founded in 1876 by Colonel Eli Lilly with the aim of manufacturing pharmaceutical products of the highest quality. Eli Lilly began his career in the pharmacy industry and opened his own pharmacy in Indianapolis in 1876. He quickly developed his own medications and eventually established Eli Lilly and Company in 1901. Over the years, the company has continued to evolve and expand its business into numerous areas. Eli Lilly is focused on biopharmaceutical research and development and operates in areas such as oncology, diabetes, neurology, and others. The company's main goal is to develop drugs that can change and improve lives. Eli Lilly invests a high percentage of its revenue into research and development every year. The company has several strategic business units, including human pharmaceuticals, animal pharmaceuticals, and oncology research. Eli Lilly is divided into five main divisions: diabetes, oncology, immunology, neurology, and animal health. The diabetes division focuses on manufacturing insulin products and glucose sensors for the treatment of type 1 and type 2 diabetes, as well as blood glucose meters and other diabetes products. The oncology division focuses on researching and developing drugs to treat cancer. The company currently has several compounds in clinical trials, including a new preparation for the treatment of breast cancer. The immunology division focuses on products for the treatment of autoimmune and inflammatory diseases, such as psoriasis. The neurology division focuses on researching and developing drugs to treat diseases of the nervous system, such as Alzheimer's. The animal health division focuses on animal health products, such as drugs for the treatment of infections in livestock and pets. Eli Lilly is primarily known for its insulin products and treatments in the field of oncology. Some of the company's most well-known products include Humalog, Forteo, Alimta, and Cymbalta. The effectiveness and compliance of the products are monitored by a quality and safety system to ensure that patients receive the highest quality medications. In conclusion, Eli Lilly and Co. is a company with a long history and a unique business model. The company specializes in developing high-quality pharmaceutical products and has continued to evolve since its founding. Eli Lilly has become a leader in various areas such as diabetes, oncology, immunology, neurology, and animal health. They are known for their insulin products and treatments in the field of oncology. The company remains committed to expanding its reach and presence globally and continues to develop innovative products that can improve and change people's lives. Eli Lilly and ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Eli Lilly and's Sales Figures

The sales figures of Eli Lilly and originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Eli Lilly and’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Eli Lilly and's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Eli Lilly and’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Eli Lilly and Stock

How much revenue did Eli Lilly and generate this year?

Eli Lilly and has achieved a revenue of 41.8 B USD this year.

How much was the turnover of the company Eli Lilly and compared to the previous year?

The revenue of Eli Lilly and has increased by 22.48% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Eli Lilly and?

The revenue of Eli Lilly and is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Eli Lilly and measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Eli Lilly and so important for investors?

The revenue of Eli Lilly and is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Eli Lilly and pay?

Over the past 12 months, Eli Lilly and paid a dividend of 4.52 USD . This corresponds to a dividend yield of about 0.62 %. For the coming 12 months, Eli Lilly and is expected to pay a dividend of 5.73 USD.

What is the dividend yield of Eli Lilly and?

The current dividend yield of Eli Lilly and is 0.62 %.

When does Eli Lilly and pay dividends?

Eli Lilly and pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Eli Lilly and?

Eli Lilly and paid dividends every year for the past 26 years.

What is the dividend of Eli Lilly and?

For the upcoming 12 months, dividends amounting to 5.73 USD are expected. This corresponds to a dividend yield of 0.78 %.

In which sector is Eli Lilly and located?

Eli Lilly and is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eli Lilly and kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eli Lilly and from 3/8/2024 amounting to 1.3 USD, you needed to have the stock in your portfolio before the ex-date on 2/14/2024.

When did Eli Lilly and pay the last dividend?

The last dividend was paid out on 3/8/2024.

What was the dividend of Eli Lilly and in the year 2023?

In the year 2023, Eli Lilly and distributed 3.92 USD as dividends.

In which currency does Eli Lilly and pay out the dividend?

The dividends of Eli Lilly and are distributed in USD.